Abstract
Researchers this week presented data at the ESCMID Global Congress on the use of interleukin-6 as a biomarker for the early detection of sepsis in specific patient populations, including children and pregnant women.
Key Data
-
Publication Date15 April 2025
-
Primary AuthorKelsy Ketchum
-
Source360Dx
-
LanguageEnglish
Click below to visit original source: